glp-1 heart attack Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action Heart Failure: GLP-1 Drugs Help

The side effect profile is not trivial

Triquetra GLP-Activate could potentially interact with other medications

The role of glutathione in the gastrointestinal tract: a review

The straightforward answer is nosemaglutide will not show up unless a specific, targeted test for the medication is performed, which is uncommon in standard clinical practice

Clinical studies consistently show that most people who stop semaglutide or tirzepatide regain a substantial portion of the weight they lost and research suggests the regained weight is disproportionately fat rather than the lean muscle mass that may have been lost during treatment